Benefit-harm ratio of the diagnostic workup in patients with prostate cancer of Gleason score from 9 to 10. Ferraro S, Rossi RS, Biganzoli EM. Cancer 2021 Jul 23. doi: 10.1002/cncr.33811.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ferraro S, Rossi RS, Biganzoli EM. Benefit-harm ratio of the diagnostic workup in patients with prostate cancer of Gleason score from 9 to 10. Cancer 2021 Jul 23. doi: 10.1002/cncr.33811.
PMID: 34297849